small-logo
ProfessionalsCapabilitiesInsights & NewsCareersLocations
About UsAlumniOpportunity & InclusionPro BonoCorporate Social Responsibility
Stay Connected:
facebookinstagramlinkedintwitteryoutube
Site Search
  • Professionals (458)
  • Capabilities (82)
  • Experience (166)
  • Insights & News (2,182)
  • Other Results (48)

Professionals 458 results

Basil Godellas
Basil Godellas
Partner
  • Chicago
Email
+1 312-558-7237
vCard

Partner

  • Chicago
Samantha Lerner
Samantha Lerner
Partner
  • Chicago
Email
+1 312-558-6463
vCard

Partner

  • Chicago
Thomas B. Walsh
Thomas B. Walsh
Partner
  • Dallas
Email
+1 214-453-6460
vCard

Partner

  • Dallas
View All Professionals

Capabilities 82 results

Practice Area

Class Actions & Group Litigation

Winston has developed a consistent record of success handling class action cases in state and federal courts. The practice is anchored by seasoned class action lawyers, many of whom have been recognized by Chambers USA and other ranking organizations as being top practitioners in their field. Our clients rely on us to steer them through class action matters by drawing on the firm’s significant experience in resolving complex litigation using creative and aggressive arguments, across a broad range of class, collective, coordinated, and mass actions, as well multidistrict litigation. We also have succeeded at trial in several class actions—a rare occurrence....Read more

Practice Area

Real Estate

Today’s dynamic commercial real estate market calls for attorneys who bring a broad platform of skills and experience to the table. Our real estate practice offers institutional knowledge across an extensive array of real estate transactions....Read more

Practice Area

Bankruptcy Litigation & Investigations

Large corporate bankruptcies and companies in financial distress often spawn a complex web of claims by lenders, trustees, debtors, creditors, creditors’ committees, investors, shareholders, and other constituents. Attorneys in Winston & Strawn’s complex commercial litigation group and special situations and restructuring group serve as trusted advisors and resolute advocates to protect clients’ business interests and assets in multifaceted Chapter 11 cases and bankruptcy-related disputes. ...Read more

Experience 166 results

Experience

|

July 15, 2025

Atsion Commits Up to $200 Million in Strategic OFA Investment

Experience

|

June 12, 2025

Winston Serves as Lead Counsel to CGP Capital Partners in New Continuation Vehicle

Experience

|

May 9, 2025

An Am Law LOTW Shout Out-Worthy Gold Medal Victory In $Jenner

View All Experience

Insights & News 2,182 results

Client Alert

|

July 25, 2025

|

8 Min Read

From Oversight to Omission: The OCC’s New Stance on Disparate Impact Liability

In this alert, Winston’s Financial Services Industry Group takes a closer look at the OCC’s new stance on disparate impact liability and its implications for the financial services industry.
The Office of the Comptroller of the Currency (OCC) announced on July 14, 2025, that it will cease supervising banks for disparate impact liability, instructing its examiners to “no longer examine for disparate impact.”[1] Accordingly, OCC examiners will not request, review, conclude on, or follow up on matters related to a bank’s disparate impact related risk, risk analysis, or assessment processes or procedures.[2] The OCC also removed references to disparate impact liability from its fair lending examination manual. 
This policy shift follows President Trump’s April 2025 executive order mandating the elimination of disparate impact liability across federal agencies and claiming that disparate impact liability forces companies to “engage in racial balancing to avoid potentially crippling legal liability.”[3] Given the Trump administration’s approach, the OCC’s policy shift is unsurprising. But the change means financial services companies should reconsider how they evaluate and address disparate impact risk, not only from the perspective of this revised federal regulatory lens, but also with the understanding that state attorneys general and private litigants will continue to pursue disparate impact claims as long as such claims remain legally viable. 
What does this mean to you and your clients? 

In the Media

|

July 24, 2025

|

2 Min Read

Winston’s Digital Assets Lawyers Discuss the GENIUS Act with IFLR

Winston & Strawn Digital Assets Group co-chairs Kimberly Prior and Daniel Stabile and partner Yulia Makarova were featured in an IFLR article discussing the GENIUS Act and how it is set to drive new client demand, complex advisory needs, and internal investment across legal teams. On July 18, President Trump signed the stablecoin bill titled “Guiding and Establishing National Innovation for US Stablecoins Act of 2025” which marks the first federal regulatory framework for the issuance and operation of payment stablecoins in the country....Read more

Webinar

|

July 23, 2025

Real GENIUS: Landmark U.S. Federal Payment Stablecoin Legislation

Join our Digital Assets Group as we unpack the ground-breaking GENIUS Act, which establishes a federal and state regulatory framework for bank and non-bank issuers of payment stablecoins. The webinar will examine the impact of the Act on digital assets companies and financial institutions that have entered (or seek to enter) the stablecoin space. ...Read more
View All Insights & News

Other Results 48 results

Law Glossary

What Is a Class Action?

A class action is a procedural device that allows one or more persons, usually plaintiffs (though federal and state procedural rules also authorize defendant classes) to file suit on behalf of a group of similarly situated persons. Federal law defines a class action as “any civil action filed under Rule 23 of the Federal Rules of Civil Procedure or similar State statute or rule of judicial procedure authorizing an action to be brought by 1 or more representative persons as a class action.”  28 U.S.C. § 1332(d)(1)(B), (d)(8)....Read more

Law Glossary

What Statutes and Regulations Govern the Approval and Marketing of Biosimilars?

Congress passed the Biologics Price Competition and Innovation Act of 2009 (BPCIA) in 2010 an amendment of the Public Health Services Act. The BPCIA is codified at 42 U.S.C. § 262....Read more

Law Glossary

What Exclusivity Periods Are Associated with Biosimilars?

An applicant may not submit an aBLA until four years after the reference product is licensed by the FDA. (See BPCIA § 351(k).) Further, any biosimilar licenses “may not be made effective” until 12 years after the reference product was licensed. (See BPCIA § 351(l).)...Read more
Logo
facebookinstagramlinkedintwitteryoutube

Copyright © 2025. Winston & Strawn LLP

AlumniCorporate Transparency Act Task ForceDEI Compliance Task ForceEqual Rights AmendmentLaw GlossaryThe Oval UpdateWinston MinutePrivacy PolicyCookie PolicyFraud & Scam AlertsNoticesSubscribeAttorney Advertising